Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
Listen to expert insights from Princy N. Kumar, MD, and Paul E. Sax, MD, on updates and new COVID-19 data from IDWeek 2022, including data on vaccines, risk factors and risk stratification, diagnostics, therapeutics, treatment of patients with immunocompromise, and long COVID.
Decera Clinical Education Infectious Disease Podcast · Princy N Kumar MD FIDSA MACP, Paul E Sax MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:
- COVID-19 vaccines, including omicron BA.1 bivalent booster
- Risk factors for breakthrough COVID-19 infections
- COVID-19 diagnostics, including digital droplet PCR
- COVID-19 therapeutics, including:
- Nirmatrelvir plus ritonavir
- Tixagevimab plus cilgavimab
- Baricitinib
- Tocilizumab
- Inhaled interferon β-1a
- COVID-19 therapeutics and outcomes in patients with immunocompromise
- Long COVID
Presenters:
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC
Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Follow along with the downloadable slideset at:
http://bit.ly/3gkJI67
Link to full program:
http://bit.ly/3TSVthM
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.